Replies to post #86812 on Anavex Life Sciences Corp (AVXL)

[longtermbeliever]

my advisor from TD have 30+ years exp in biotech company he have pretty record in biotech will see nothing is a sure thing but will see.hold

[Reyeton]

Seems probable, they have the answer and are ready to release it. Just waiting for the most opportune time. What better timing than tomorrow after the appointment of a new CEO. Biogen took a major hit last year with the unexpected Phase 3 failure of their MS anti-lingo myelinating drug.